Publications by authors named "H Wallinger"

Introduction: Hidradenitis suppurativa (HS) is a debilitating, inflammatory skin disorder. Treatment strategies in patients with HS are challenging; real-world evidence in a HS population is warranted for greater disease understanding. The objective of this analysis was to describe real-world treatment patterns and treatment satisfaction in patients with HS.

View Article and Find Full Text PDF

Hidradenitis suppurativa (HS) is an inflammatory skin disease associated with high morbidity and disability that has limited treatment options. People from racial and ethnic minority groups may experience greater disease severity and delay to diagnosis. This study assessed the impact of race/ethnicity on HS diagnosis and management in real-world clinical settings.

View Article and Find Full Text PDF
Article Synopsis
  • Hidradenitis suppurativa (HS) uniquely affects patients' quality of life (QoL), and current general patient-reported outcome measures (PROMs) may not adequately capture this impact, highlighting the need for a HS-specific PROM.
  • The study aimed to validate the Hidradenitis Suppurativa Quality of Life Questionnaire (HiSQOL) by comparing its results with the Dermatology Life Quality Index (DLQI) through a survey involving 677 HS patients across multiple countries.
  • Findings showed a strong correlation (0.87) between HiSQOL and DLQI scores, indicating that HiSQOL effectively reflects QoL issues specific to HS, particularly in areas like embarrassment, depression, and anxiety, which were
View Article and Find Full Text PDF

Background: Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating skin disease characterized by painful deep lesions and associated with substantial disease burden.

Objectives: The objective of this study was to describe physician- and patient-reported clinical unmet needs from a real-world perspective.

Methods: This study used data from the Adelphi HS Disease Specific Programme, a point-in-time survey of dermatologists and their patients with HS in Europe and the United States.

View Article and Find Full Text PDF